Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries
PLOS ONE · 23.06.2023 · 18 (6) · e0287587
DOI: 10.1371/journal.pone.0287587 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS ONE, online erschienen am 23.06.2023. Verfasst von Judith Honing und 6 weiteren Autor:innen. Beteiligte Einrichtung: Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Gastritis, Atrophic, Stomach Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gastric atrophy (GA) and gastric intestinal metaplasia (GIM) are precursor conditions to gastric adenocarcinoma (GAC) and should be monitored endoscopically in selected individuals. However, little is known about adherence to recommendations in clinical practice in low-risk countries.
Objective
The aim of this study was to evaluate endoscopic recognition and adequacy of surveillance for GA and GIM in countries with low GAC prevalence.
Methods
We retrospectively analysed patients diagnosed with GIM or GA in three centers in The Netherlands and UK between 2012 and 2019. Cases with GIM and/or GA diagnosis at index endoscopy were retrieved through systematic search of pathology databases using ‘gastric’ and ‘intestinal metaplasia’ or ‘atrophy’ keywords. Endoscopy reports were analysed to ascertain accuracy of endoscopic diagnoses. Adequacy of surveillance was assessed following histological diagnosis at the index endoscopy based on ESGE guidelines published in 2012.
Results
We included 396 patients with a median follow-up of 57.2 months. Mean age was 66 years and the rates of antrum-predominant versus extensive GIM were comparable (37% vs 38%). Endoscopic recognition rates were 48.5% for GA and 16.3% for GIM. Surveillance was adequately carried out in 215 of 396 patients (54.3%).
Conclusion
In countries with a low incidence of GAC, the rate of endoscopic recognition of gastric pre-cancerous lesions and adherence to surveillance recommendation are low. Substantial improvement is required in endoscopic training and awareness of guidelines recommendation in order to optimise detection and management of pre-malignant gastric conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
- Department of Gastroenterology, Vilnius, Lithuania.
- Department of Pathology, University of Cambridge, Addenbrooke's University Hospital, Cambridge, United Kingdom.
- Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, The Netherlands.
ORCID-Profile: Judith Honing, Massimiliano di Pietro
Zitieren
APA
Honing, J., Keith Tan, W., Dieninyte, E., O'Donovan, M., Brosens, L., Weusten, B., & di Pietro, M. (2023). Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries. PLOS ONE, 18(6), e0287587. https://doi.org/10.1371/journal.pone.0287587
Vancouver
Honing J, Keith Tan W, Dieninyte E, O'Donovan M, Brosens L, Weusten B, et al. Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries. PLOS ONE. 2023;18(6):e0287587. doi:10.1371/journal.pone.0287587
BibTeX
@article{Honing2023,
author = {Honing, Judith and Keith Tan, W and Dieninyte, Egle and O'Donovan, Maria and Brosens, Lodewijk and Weusten, Bas and di Pietro, Massimiliano},
title = {Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {6},
pages = {e0287587},
doi = {10.1371/journal.pone.0287587}
}
EUVIMED